以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
NVO
19 atoms · 跨 7 天 · 首见 2026-04-17 · 最近 2026-06-11
三色: 🟦 fact 17 · 🟥 take 2 · stance ▲3/▼4/◆0
来源: X 19
时态: fresh:17 · stale:2
标签: 好信源:11 · 好数字:11
预测 (forecast) (1)
- 2026-06-11 · Wegovy pill availability timeline
Novo expects availability via private prescription within weeks.
tags: 好信源 · → daily
value: date=within weeks
立场 (position) (2)
展开 2 条老旧 / 已过期
- 2026-05-11
[老旧] · TD Cowen target price
TD Cowen reiterates Hold, maintains PT at $42
tags: 好信源 · → daily
value: qty=$42 · date=2026-05-11
- 2026-05-11
[老旧] · potential downside
Downside: -8.8%
tags: 好数字 · → daily
value: qty=-8.8% · date=2026-05-11
事实 (fact) (16)
- 2026-06-11 ⭐ · OASIS 4 trial weight loss result
OASIS 4 trial: approximately 14% weight loss versus 2% placebo.
tags: 好数字·好信源 · → daily
value: qty=14%
- 2026-06-11 ⭐ · OASIS 4 trial adherence-adjusted weight loss
Treatment-adherent participants achieved approximately 17% weight loss.
tags: 好数字·好信源 · → daily
value: qty=17%
- 2026-06-11 ⭐ · Wegovy pill discontinuation rate due to adverse events
About 7% discontinued treatment due to adverse events.
tags: 好数字·好信源 · → daily
value: qty=7%
- 2026-06-11 · UK approval status
UK approves Wegovy pill, oral semaglutide for weight management.
tags: 好信源 · → daily
value: date=2026-06-11
- 2026-06-11 · UK approval first in Europe
UK becomes Europe's first country authorizing the treatment.
tags: 好信源 · → daily
- 2026-05-06 · generics Ozempic delayed in China
Novo sees generic Ozempic delayed in China until next year
tags: 好信源 · → daily
value: date=next year
- 2026-06-11 · ADR 股价走势
NOVO NORDISK ADRS LOSES GAINS FOLLOWING SECURITY INCIDENT REPORT.
tags: 好信源 · → daily
value: direction=下跌
- 2026-06-04 · FWD P/E
$NVO at 14 FWD P/E
tags: 好数字 · → daily
value: qty=14
- 2026-05-11 · current price
Current Price: $46.07
tags: 好数字 · → daily
value: qty=$46.07 · date=2026-05-11
- 2026-05-06 · 季度每股收益
实际每股收益 (Actual EPS): $1.04
tags: 好数字 · → daily
value: qty=$1.04 · date=Q1-2026
- 2026-05-06 · 季度营收
实际营收 (Actual Revenue): $15.17B
tags: 好数字 · → daily
value: qty=$15.17B · date=Q1-2026
- 2026-05-06 · 季度营收超预期幅度
营收超预期幅度 (Revenue Beat): +34.25%
tags: 好数字 · → daily
value: qty=+34.25% · date=Q1-2026
- 2026-05-06 · 实际营收
NVO(诺和诺德)实际营收: 15.17B
tags: 好数字 · → daily
- 2026-05-04 · 股价变动
Novo Nordisk gains 2%
tags: 好数字 · → daily
value: qty=+2%
- 2026-05-01 · 财报发布日期
Companies Reporting Earnings Next Week $NVO
tags: 好信源 · → daily
value: date=2026-05-04/2026-05-08
- 2026-04-17 · 合作伙伴关系状态
$NVO de-risking + partnership
tags: 好信源 · → daily
value: direction=positive
时间轴 (近 20)
- 2026-06-11 ·
fact · UK approval status · → daily
- 2026-06-11 ·
fact · UK approval first in Europe · → daily
- 2026-06-11 ·
fact · OASIS 4 trial weight loss result · → daily
- 2026-06-11 ·
fact · OASIS 4 trial adherence-adjusted weight loss · → daily
- 2026-06-11 ·
fact · Wegovy pill discontinuation rate due to adverse events · → daily
- 2026-06-11 ·
forecast · Wegovy pill availability timeline · → daily
- 2026-06-11 ·
fact · ADR 股价走势 · → daily
- 2026-06-04 ·
fact · FWD P/E · → daily
- 2026-05-11 ·
position · TD Cowen target price · → daily
- 2026-05-11 ·
fact · current price · → daily
- 2026-05-11 ·
position · potential downside · → daily
- 2026-05-06 ·
fact · 季度每股收益 · → daily
- 2026-05-06 ·
fact · 季度营收 · → daily
- 2026-05-06 ·
fact · 季度营收超预期幅度 · → daily
- 2026-05-06 ·
fact · generics Ozempic delayed in China · → daily
- 2026-05-06 ·
fact · 实际营收 · → daily
- 2026-05-04 ·
fact · 股价变动 · → daily
- 2026-05-01 ·
fact · 财报发布日期 · → daily
- 2026-04-17 ·
fact · 合作伙伴关系状态 · → daily
← 实体目录 · 系统日志